D
Arbutus Biopharma Corporation ABUS
$4.42 -$0.02-0.34% NASDAQ
Recommendation
Prev Close
$4.43
Volume
249,739
Avg Vol (90D)
1,092,809
Market Cap
$852.00M
Dividend & Yield
--
52-Week Range
$2.71 - $5.10
P/E (TTM)
--
EPS (TTM)
-$0.23
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Arbutus Biopharma (ABUS, $4.17) Aroon Indicator entered a Downtrend on December 02, 2025.
12/3/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.21) Aroon Indicator entered a Downtrend on December 01, 2025.
12/2/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.41) Aroon Indicator entered a Downtrend on November 28, 2025.
11/29/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.41) Stochastic Oscillator left the oversold zone on November 26, 2025
11/27/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.27) Stochastic Oscillator left the oversold zone on November 19, 2025
11/20/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.27) price may climb as it broke lower Bollinger Band on Nov 19, 2025
11/20/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.45) price exceeded its 50-day Moving Average on November 18, 2025
11/19/2025 - Tickeron - Stocks
Arbutus Biopharma (NASDAQ:ABUS) Given Buy Rating at Chardan Capital
11/16/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Downgraded by Wall Street Zen to Hold
11/16/2025 - MarketBeat
Chardan Capital Maintains Arbutus Biopharma (ABUS) Buy Recommendation
11/15/2025 - Nasdaq News: Stocks
Arbutus Biopharma (ABUS) Receives Steady Buy Rating from Chardan Capital ABUS Stock News
11/14/2025 - GuruFocus
Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
11/14/2025 - MarketBeat
Commit To Purchase Arbutus Biopharma At $3, Earn 33.8% Annualized Using Options
11/14/2025 - Stock Options Channel
Arbutus Biopharma (ABUS, $4.56) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 13, 2025
11/14/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.56) entered Downtrend as Momentum indicator drops below 0 level on Nov 13, 2025
11/14/2025 - Tickeron - Stocks
Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)
11/13/2025 - TipRanks Financial Blog
Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)
11/13/2025 - The Fly
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/13/2025 - Globe Newswire
Arbutus Biopharma (ABUS, $4.84) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 12, 2025
11/13/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.44) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 6, 2025
11/7/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.84) price may drop as it broke higher Bollinger Band on Oct 30, 2025
10/31/2025 - Tickeron - Stocks
Arbutus Biopharma (ABUS, $4.61) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 29, 2025
10/30/2025 - Tickeron - Stocks
Analysts See 14% Gains Ahead For SMMV
10/28/2025 - ETF Channel
Arbutus Biopharma (NASDAQ:ABUS) Receives "Sell (D-)" Rating from Weiss Ratings
10/25/2025 - MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Passes Above 200-Day Moving Average - Time to Sell?
10/25/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$14.61M
EBITDA (TTM)
-$30.67M
EBIT (TTM)
-$31.36M
Net Income (TTM)
-$42.28M
Balance Sheet
Total Assets (Q)
$97.71M
Total Debt (Q)
$4.61M
Total Liabilities (Q)
$20.31M
Book Value Per Share (Q)
$0.4032
Cash Flow
Cash from Operations (TTM)
-$45.27M
Cash from Investing (TTM)
$30.35M
Cash from Financing (TTM)
$5.50M
Net Change in Cash (TTM)
-$9.44M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
0.67
7-Day Total Return
3.40%
30-Day Total Return
-0.34%
60-Day Total Return
-4.44%
90-Day Total Return
33.79%
Year to Date Total Return
34.19%
1-Year Total Return
18.05%
2-Year Total Return
114.32%
3-Year Total Return
81.69%
5-Year Total Return
10.10%
52-week Low
Apr 09, 2025 - $2.71
52-week High
Sep 11, 2025 - $5.10
Valuation
Market Cap
$852.00M - Small Cap
Enterprise Value
$762.90M
Price/Sales (TTM)
58.21
Price/Book (Q)
10.99
Dividends and Shares
Shares Outstanding
191.78
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arbutusbio.com
Phone Number
267 469 0914
Address
701 Veterans Circle
Warminster, PA 18974
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline... more
NASDAQ 12/04/2025 1:51PM Eastern Quotes delayed